3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Colorectal Neoplasms
249
Rectal Neoplasms
154
Pancreatic Neoplasms
125
Stomach Neoplasms
105
Colonic Neoplasms
104
Esophageal Neoplasms
90
Neoplasm Metastasis
69
Breast Neoplasms
61
Squamous Cell Carcinoma of Head and Neck
47
Carcinoma, Hepatocellular
42
Adenocarcinoma Of Esophagus
41
Head and Neck Neoplasms
39
Esophageal Squamous Cell Carcinoma
38
Neoplasms
37
Nasopharyngeal Carcinoma
30
Adenocarcinoma
24
Cholangiocarcinoma
20
Keratosis, Actinic
17
Carcinoma, Squamous Cell
16
Biliary Tract Neoplasms
16
Liver Neoplasms
15
Gastrointestinal Neoplasms
15
Anus Neoplasms
14
Gallbladder Neoplasms
11
Bile Duct Neoplasms
11
Peritoneal Neoplasms
10
Laryngeal Neoplasms
9
Recurrence
8
Nasopharyngeal Neoplasms
7
Colorectal Cancer Metastatic
7
Interventions
Photochemotherapy
2
Metformin
2
Biopsy
2
Tomography, Optical Coherence
1
Tobacco Products
1
Surveys and Questionnaires
1
Sulindac
1
Specimen Handling
1
Photosensitizing Agents
1
Nivolumab
1
Melatonin
1
Fluorouracil
1
Fluconazole
1
Ethanol
1
Dihematoporphyrin Ether
1
Celecoxib
1
Catechin
1
Behavior Therapy
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukoplakia, Oral
×
Fluorouracil
×
Clear all
NCT05505539
2022-09-22
OL_5FU
University of California, San Francisco
Phase 1
Withdrawn